News & Updates

Show Multimedia Only
Fenofibrate staves off vision loss in diabetes
Fenofibrate staves off vision loss in diabetes
08 Aug 2024 byElvira Manzano

The antilipidemic drug fenofibrate averts or delays diabetic retinopathy (DR) in diabetes patients with early retinal changes in the LENS trial, potentially paving the way for the least invasive route of drug delivery in this population.

Fenofibrate staves off vision loss in diabetes
08 Aug 2024
First-line use of dual immunotherapy in a patient with unresectable HCC
First-line use of dual immunotherapy in a patient with unresectable HCC
08 Aug 2024
Dolutegravir plus lamivudine suppresses HIV without HBV reactivation
Dolutegravir plus lamivudine suppresses HIV without HBV reactivation
07 Aug 2024
Gut microbiota may unlock new diagnostic and treatment strategies for autism
Gut microbiota may unlock new diagnostic and treatment strategies for autism
07 Aug 2024 byKanas Chan

Gut microbiota biomarkers show >90 percent sensitivity and specificity in diagnosing autism spectrum disorder (ASD). Gut microbiome modulation with a novel synbiotic formula, SCM06, may alleviate anxiety symptoms in children with ASD, according to researchers from the Chinese University of Hong Kong (CUHK).

Gut microbiota may unlock new diagnostic and treatment strategies for autism
07 Aug 2024